Brief: Siegfried To Acquire High-Quality Small Molecules Drug Substance Capacity In The Us
27/01/2026 05:33
Jan 27 (Reuters) - SIEGFRIED HOLDING AG SFZN.S: TO ACQUIRE HIGH-QUALITY SMALL MOLECULES DRUG SUBSTANCE CAPACITY IN THE US ACQUISITION INCLUDES NORAMCO, PURISYS, AND EXTRACTAS BIOSCIENCE DEAL EXPECTED TO CLOSE LATER THIS YEAR ACQUISITION WILL BE FINANCED THROUGH EXISTING AND NEW DEBT INSTRUMENTS Source text: ID:nEQbb0byNa Further company coverage: SFZN.S (Gdansk Newsroom) ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))